SCHEMBL18250565

SCHEMBL18250565

CC(=O)/C=C/c1c[nH]c2ncc(C(=O)c3ccccc3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ AAK1 Q2M2I8 1/20 0.42
▸ SGK1 O00141 3/20 0.41
▸ AXL P30530 7/20 0.40
▸ NEK1 Q96PY6 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18250576 0.88 TDO2 (0.41) RAB9ANPC1SMN1; SMN2AAK1SGK1
SCHEMBL18238325 0.88 MAP3K7 (0.47) ALDH1A1RAB9AMEN1NPC1MAPT
SCHEMBL16945216 0.88 MAP3K7 (0.47) ALDH1A1RAB9AMEN1NPC1MAPT
SCHEMBL18250494 0.83 AXL (0.57) SGK1AXLNEK1GSK3BRIPK1
SCHEMBL18250580 0.81 MAP4K1 (0.43) MAPTSGK1ABL1ITKMAP3K7
SCHEMBL18250498 0.80 GSK3B (0.42) ALDH1A1RAB9AMEN1NPC1MAPT
SCHEMBL18250503 0.79 CSNK1G2 (0.54) SGK1AXLNEK1GSK3BCDC7
SCHEMBL16949043 0.77 AXL (0.53) AAK1SGK1AXLNEK1GSK3B
SCHEMBL18238242 0.77 AXL (0.53) AAK1SGK1AXLNEK1GSK3B
SCHEMBL18250540 0.77 DRD4 (0.39) ALDH1A1RAB9AMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499551-B2 Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases CONFLUENCE LIFE SCIENCES, INC. (US) 2016-11-22 — — US disclosed
Send feedback